Related Experiment Video
Updated: Sep 3, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Immunotherapy: Reshape the Tumor Immune Microenvironment.
Bingzhe Lv1,2, Yunpeng Wang1,2, Dongjiang Ma1,2
1Department of General Surgery, Lanzhou University Second Hospital, Lanzhou, China.
Immunotherapy reshapes the tumor immune microenvironment (TIME) to restore anti-tumor immunity. Understanding TIME changes guides development of novel combination cancer immunotherapy strategies.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- The tumor immune microenvironment (TIME) comprises cells, cytokines, and interactions that dictate anti-tumor immunity.
- Tumors evade immune surveillance by creating an immunosuppressive TIME, despite the immune system's potential to eliminate cancer via the cancer-immune cycle.
Purpose of the Study:
- To review the role of immune cells within the TIME.
- To discuss how current immunotherapies remodel the TIME.
- To explore how TIME modifications inform combination treatment strategies.
Main Methods:
- Literature review of immune cell functions in the TIME.
- Analysis of current mainstream immunotherapeutic approaches.
- Examination of TIME alterations induced by immunotherapy.
Main Results:
- Immune cells and their interactions within the TIME are crucial for anti-tumor responses.
- Immunotherapies can reprogram the TIME, enhancing anti-tumor immune cell activity.
- Distinct TIME changes under immunotherapy suggest potential for synergistic treatment combinations.
Conclusions:
- Understanding the dynamic TIME is key to effective cancer immunotherapy.
- Immunotherapy's ability to reshape the TIME offers opportunities for improved treatment efficacy.
- Further research into TIME modulation can lead to optimized combination therapies for cancer treatment.
More Related Videos
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
08:32Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Published on: June 7, 2018
Related Concept Videos
Tumor Immunotherapy
The Tumor Microenvironment
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...